Refractory epilepsy associated with anti-ribosomal P antibodies successfully treated with topiramate
Abstract
We report the case of a 25-year-old woman who developed temporal lobe epilepsy associated with systemic lupus erythematosus (SLE). Serum and cerebrospinal fluid samples showed high titers of anti-ribosomal P (anti-P) antibodies with negative anti-NMDAR antibodies. She was receiving prednisone and azathioprine, with normalization of SLE serum markers, but without changes in titers of anti-P antibodies. No seizure control was achieved using valproic acid, levetiracetam and lamotrigine. However, she had a selective response to topiramate, an AMPAR blocker, maintained during 6 years of follow-up. We discuss the pathophysiology of this autoimmune epilepsy associated with high titer anti-P antibodies.
Más información
Título según WOS: | Refractory epilepsy associated with anti-ribosomal P antibodies successfully treated with topiramate |
Título según SCOPUS: | Refractory epilepsy associated with anti-ribosomal P antibodies successfully treated with topiramate |
Volumen: | 340 |
Fecha de publicación: | 2020 |
Idioma: | English |
DOI: |
10.1016/j.jneuroim.2020.577144 |
Notas: | ISI, SCOPUS |